BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34435059)

  • 1. Identification of Novel miRNAs in the F8 Gene Via Bioinformatics Tools.
    Rezaei H; Motovali-Bashi M; Khalilian S
    Iran J Biotechnol; 2021 Apr; 19(2):e2700. PubMed ID: 34435059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA and Hemophilia-A Disease: Bioinformatics Prediction and Experimental Analysis.
    Rezaei H; Motovali-Bashi M; Mowla SJ
    Cell J; 2021 Aug; 23(3):341-348. PubMed ID: 34308578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental validation of a predicted microRNA within human
    Jalali-Qomi S; Motovali-Bashi M; Rezaei H; Khalilian S
    Mol Biol Res Commun; 2021 Jun; 10(2):45-53. PubMed ID: 34316492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical manifestation of hemophilia A in the absence of mutations in the F8 gene that encodes FVIII: role of microRNAs.
    Jankowska KI; McGill J; Pezeshkpoor B; Oldenburg J; Atreya CD; Sauna ZE
    Transfusion; 2020 Feb; 60(2):401-413. PubMed ID: 31785023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further Evidence That MicroRNAs Can Play a Role in Hemophilia A Disease Manifestation:
    Jankowska KI; McGill J; Pezeshkpoor B; Oldenburg J; Sauna ZE; Atreya CD
    Front Cell Dev Biol; 2020; 8():669. PubMed ID: 32850803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics prediction and experimental validation of a novel microRNA: hsa-miR-B43 within human CDH4 gene with a potential metastasis-related function in breast cancer.
    Rahimi A; Sedighi R; Emadi-Baygi M; Honardoost MA; Mowla SJ; Khanahmad H; Nikpour P
    J Cell Biochem; 2020 Feb; 121(2):1307-1316. PubMed ID: 31489987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First report of molecular diagnosis of Tunisian hemophiliacs A: identification of 8 novel causative mutations.
    Elmahmoudi H; Khodjet-el-khil H; Wigren E; Jlizi A; Zahra K; Pellechia D; Vinciguerra C; Meddeb B; Elggaaied AB; Gouider E
    Diagn Pathol; 2012 Aug; 7():93. PubMed ID: 22883072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsa-miR-5581-3p and Hsa-miR-542-3p Target the
    Meng F
    Mediterr J Hematol Infect Dis; 2021; 13(1):e2021041. PubMed ID: 34276910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: Identification of a
    Bai H; Xue X; Tian L; Liu XT; Li Q
    Front Genet; 2020; 11():589899. PubMed ID: 33747028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small ncRNA Expression-Profiling of Blood from Hemophilia A Patients Identifies miR-1246 as a Potential Regulator of Factor 8 Gene.
    Sarachana T; Dahiya N; Simhadri VL; Pandey GS; Saini S; Guelcher C; Guerrera MF; Kimchi-Sarfaty C; Sauna ZE; Atreya CD
    PLoS One; 2015; 10(7):e0132433. PubMed ID: 26176629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of FVIII Function and Phenotypic Rescue in Hemophilia A Mice by Transplantation of MSCs Derived From
    Qiu L; Xie M; Zhou M; Liu X; Hu Z; Wu L
    Front Cell Dev Biol; 2021; 9():630353. PubMed ID: 33644070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of 95 novel mutations in coagulation factor VIII gene F8 responsible for hemophilia A: results from a single institution.
    Guillet B; Lambert T; d'Oiron R; Proulle V; Plantier JL; Rafowicz A; Peynet J; Costa JM; Bendelac L; Laurian Y; Lavergne JM
    Hum Mutat; 2006 Jul; 27(7):676-85. PubMed ID: 16786531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FVIII Immunogenicity-Bioinformatic Approaches to Evaluate Inhibitor Risk in Non-severe Hemophilia A.
    Hart DP
    Front Immunol; 2020; 11():1498. PubMed ID: 32849511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep intronic F8 c.5999-27A>G variant causes exon 19 skipping and leads to moderate hemophilia A.
    Wang X; Hu Q; Tang N; Lu Y; Deng J
    Blood Coagul Fibrinolysis; 2020 Oct; 31(7):476-480. PubMed ID: 32833809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of deep intronic variants in 15 haemophilia A patients by next generation sequencing of the whole factor VIII gene.
    Bach JE; Wolf B; Oldenburg J; Müller CR; Rost S
    Thromb Haemost; 2015 Oct; 114(4):757-67. PubMed ID: 25948085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transduction of modified factor VIII gene improves lentiviral gene therapy efficacy for hemophilia A.
    Gong J; Chung TH; Zheng J; Zheng H; Chang LJ
    J Biol Chem; 2021 Dec; 297(6):101397. PubMed ID: 34774524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of novel miRNAs and associated target genes in Glycine max.
    Joshi T; Yan Z; Libault M; Jeong DH; Park S; Green PJ; Sherrier DJ; Farmer A; May G; Meyers BC; Xu D; Stacey G
    BMC Bioinformatics; 2010 Jan; 11 Suppl 1(Suppl 1):S14. PubMed ID: 20122185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Possible Non-Mutational Causes of FVIII Deficiency: Non-Coding RNAs and Acquired Hemophilia A.
    Zimta AA; Hotea I; Brinza M; Blag C; Iluta S; Constantinescu C; Bashimov A; Marchis-Hund EA; Coudsy A; Muller-Mohnssen L; Dirzu N; Gulei D; Dima D; Serban M; Coriu D; Tomuleasa C
    Front Med (Lausanne); 2021; 8():654197. PubMed ID: 33968959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation (4040-4045 nt. delA) in exon 14 of the factor VIII gene causing severe hemophilia A.
    Onsori H; Feizi MA; Feizi AA
    Indian J Hum Genet; 2011 Sep; 17(3):232-4. PubMed ID: 22345999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of four novel molecular changes in the promoter region of the factor VIII gene.
    Nougier C; Roualdes O; Fretigny M; d'Oiron R; Costa C; Negrier C; Vinciguerra C
    Haemophilia; 2014 Mar; 20(2):e149-56. PubMed ID: 24372689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.